Treatment of extranodal lymphomas

被引：28

作者：

Zucca, E ^{[1
]}

Conconi, A

Cavalli, F

机构：

[1] Osped San Giovanni Bellinzona, Oncol Inst So Switzerland, Int Extranodal Lymphona Study Grp, CH-6500 Bellinzona, Switzerland

[2] Amedeo Avogradro Univ Eastern Piedmont, Azienda Ospedaliera Maggiore della Carita, Div Internal Med, Ctr Study & Treatment Blood Disorders, I-28100 Novara, Italy

来源：

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2002年 / 15卷 / 03期

关键词：

non-Hodgkin's lymphoma; extranodal; therapy; MALT lymphoma; angiocentric T/NKlymphoma; mycosis fungoides; stomach; skin; CNS; testis;

D O I：

10.1053/beha.2002.0218

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

At least one-quarter of the non-Hodgkin's lymphomas arise primarily at extranodal sites. The rising incidence of non-Hodgkin's lymphomas, observed over recent decades, have mainly affected the primary extranodal entities. Survival rates vary among the specific sites of primary extranodal lymphomas. This is due partly to differences in natural history, related mainly to the histological type but also to differences in management strategy which are related to organ-specific problems. Few controlled studies facilitate therapeutic decisions in this setting. This chapter represents a general overview of the available data.

引用

页码：533 / 547

页数：15

共 96 条

[11]

Chan JKC, 2001, Pathology and genetics of tumours of haematopoietic and lymphoid tissues, P204

[12] Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach [J].

Chen, LT ;

Lin, JT ;

Shyu, RY ;

Jan, CM ;

Chen, CL ;

Chiang, IP ;

Liu, SM ;

Su, IJ ;

Cheng, AL .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) :4245-4251

[13] PRIMARY B-CELL GASTRIC LYMPHOMA - A CLINICOPATHOLOGICAL STUDY OF 145 PATIENTS [J].

COGLIATTI, SB ;

SCHMID, U ;

SCHUMACHER, U ;

ECKERT, F ;

HANSMANN, ML ;

HEDDERICH, J ;

TAKAHASHI, H ;

LENNERT, K .

GASTROENTEROLOGY, 1991, 101 (05) :1159-1170

[14] Does surgery belong to medical history for gastric lymphomas? [J].

Coiffier, B ;

Salles, G .

ANNALS OF ONCOLOGY, 1997, 8 (05) :419-421

[15]

Conconi A, 2001, BLOOD, V98, p807A

[16] TESTICULAR LYMPHOMA - IMPROVED OUTCOME WITH EARLY BRIEF CHEMOTHERAPY [J].

CONNORS, JM ;

KLIMO, P ;

VOSS, N ;

FAIREY, RN ;

JACKSON, S .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :776-781

[17] Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma [J].

Cortelazzo, S ;

Rossi, A ;

Roggero, E ;

Oldani, E ;

Zucca, E ;

Tondini, C ;

Ambrosetti, A ;

Pasini, F ;

Pinotti, G ;

Bertini, M ;

Vitolo, U ;

Busetto, M ;

Gianni, L ;

Cavalli, F ;

Barbui, T .

ANNALS OF ONCOLOGY, 1999, 10 (12) :1433-1440

[18] Frequency of clonal intraepithelial T lymphocyte proliferations in enteropathy-type intestinal T cell lymphoma, coeliac disease, and refractory sprue [J].

Daum, S ;

Weiss, D ;

Hummel, M ;

Ullrich, R ;

Heise, W ;

Stein, H ;

Riecken, EO ;

Foss, HD .

GUT, 2001, 49 (06) :804-812

[19] Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: An international survey [J].

de Jong, D ;

Aleman, BMP ;

Taal, BG ;

Boot, H .

ANNALS OF ONCOLOGY, 1999, 10 (03) :275-280

[20] Histological grading in gastric lymphoma: Pretreatment criteria and clinical relevance [J].

DeJong, D ;

Boot, H ;

VanHeerde, P ;

Hart, GAM ;

Taal, BG .

GASTROENTEROLOGY, 1997, 112 (05) :1466-1474

← 1 2 3 4 5 6 7 8 9 10 →